X Zhao, Y Jin, L Li, L Xu, Z Tang, Y Qi, L Yin… - Pharmacological …, 2019 - Elsevier
As one classic anticancer drug, clinical application of Doxorubicin (Dox) is limited due to its
side effects. In our previous work, we have investigated the drug targets to treat Dox-induced …